Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/2274
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLawrentschuk, Nathan-
dc.contributor.otherHomewood, David-
dc.contributor.otherO'Brien, Jonathan-
dc.contributor.otherManning, Todd-
dc.contributor.otherKelly, Brian-
dc.contributor.otherChan, Phillip-
dc.contributor.otherThomas, Ben-
dc.date2023-10-03-
dc.date.accessioned2023-11-13T03:04:17Z-
dc.date.available2023-11-13T03:04:17Z-
dc.date.issued2023-10-
dc.identifier.citationBJU Int . 2023 Oct 3en_US
dc.identifier.issn1464-4096en_US
dc.identifier.issn1464-410Xen_US
dc.identifier.urihttp://hdl.handle.net/11434/2274-
dc.description.abstractRetroperitoneal lymph node dissection (RPLND) is an important part of multimodal therapy for node-positive germ cell malignancy [1-4]. However, due to wide heterogeneity in patient status, disease biology and tumour locations, RPLND can be challenging and risky [1]. One such risk is iatrogenic chylous ascites (CA; 8% of cases) [1]. CA is defined as accumulation of chyle, a lipid-rich lymph fluid in the peritoneal cavity [5]. Morbidity from intra-abdominal chyle extravasation includes delayed wound healing, malnutrition, electrolyte disturbances, and immunosuppression [2, 6]. This morbidity impairs postoperative recovery, delays adjuvant oncological therapy, and detrimentally affects quality of life [2, 4]. Limited reliable data exist to describe the management of this complex condition [1]. We outline a difficult case and then review the literature for treatment strategies and propose a contemporary management algorithm for refractory post-RPLND CA.en_US
dc.publisherBlackwell Scienceen_US
dc.subjectChyle Leaken_US
dc.subjectRetroperitoneal Lymph Node Dissectionen_US
dc.subjectRPLNDen_US
dc.subjectMalignancyen_US
dc.subjectChylous Ascitesen_US
dc.subjectRetroperitoneal Lymphadenopathyen_US
dc.subjectGlue Embolizationen_US
dc.subjectCancer Services, Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleCase of the month from University of Melbourne, Australia: refractory chyle leak after retroperitoneal lymph node dissection with updated algorithm.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1111/bju.16188en_US
dc.identifier.journaltitleBJU internationalen_US
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/37789671/en_US
dc.description.affiliatesDepartment of Surgery, Royal Melbourne Hospital, University of Melbourne, Victoria, Australiaen_US
dc.description.affiliatesDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Victoria, Australiaen_US
dc.description.affiliatesDepartment of Urology, Western Health, Victoria, Australiaen_US
dc.description.affiliatesDepartment of Surgery, Bendigo Hospital, Victoria, Australiaen_US
dc.type.studyortrialCase Reportsen_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services

Files in This Item:
File Description SizeFormat  
Case of the Month from University of Melbourne.pdf334.67 kBAdobe PDFThumbnail
View/Open


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.